Skip to content
Homepage
Author:
Sunshine Biopharma Inc.
Posted Date:
August 7, 2026
Sunshine Biopharma Launches Amoxicillin in Canada and Begins Pharmacy Shipments, Targeting an Estimated $4.9 Billion Global Market
Sunshine Biopharma Inc.
August 7, 2026
Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval
Sunshine Biopharma Inc.
August 4, 2026
Health Canada Approves Sunshine Biopharma’s Ondansetron for Treatment of Chemotherapy-Induced Nausea and Vomiting
Sunshine Biopharma Inc.
July 28, 2026
Sunshine Biopharma and University of Arizona Publish Significant New Research Findings
Sunshine Biopharma Inc.
July 20, 2026
Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Arimidex(R)
Sunshine Biopharma Inc.
June 25, 2026
